Email this article to a friend
A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension
BMC Ophthalmology 2012, 12:9 doi:10.1186/1471-2415-12-9
